Health

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a…

4 months ago

Boehringer Ingelheim announces appointment to Board of Managing Directors

Harsha Deshmukh has been appointed a member of the Board of Managing Directors with responsibility for IT and Global Business…

4 months ago

Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Nov. 28,…

4 months ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 28, 2025 08:00 ET  | Source: Spero Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics,…

4 months ago

GENFIT Announces Appointment of new Chief Medical Officer

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to…

4 months ago

Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Womens Healthcare Innovation

New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism…

4 months ago

Report finds adoption of barcoding system in Canadian healthcare can save billions annually while supporting patient safety

November 27, 2025 09:30 ET  | Source: GS1 Canada TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared…

4 months ago

PetMeds Extends Existing Shareholder Rights Plan

November 26, 2025 16:05 ET  | Source: PetMed Express, Inc. DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed…

4 months ago

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors

BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on…

4 months ago

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…

4 months ago